Eovist

DRUG2 trials

Sponsors

National Cancer Institute (NCI), Massachusetts General Hospital

Conditions

Hepatocellular CarcinomaProstate Cancer

Early Phase 1

24hr Imaging Of HCC After EOVIST

WithdrawnNCT01968629

Massachusetts General HospitalHepatocellular Carcinoma

Start: 2013-12-31End: 2015-07-31Updated: 2015-09-23

Phase 2

Gadoxetate Enhanced Imaging Study to Detect Prostate Cancer

CompletedNCT01867424

National Cancer Institute (NCI)Prostate Cancer

Start: 2013-05-14End: 2016-12-08Updated: 2020-07-08